Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPN

Clinical trial NCT07710534 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07710534
Sponsor: Virginia Commonwealth University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsed / Refractory AML High Risk Myelodysplastic Syndrome High Risk Myeloproliferative Neoplasms

Start date: 2026-09-30
Primary completion: 2031-09-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.